−0.004 AUD
−3.44 M AUD
0.00 AUD
729.96 M
About BIOTRON LIMITED
Sector
Industry
CEO
Michelle Miller
Website
Headquarters
North Ryde
Founded
1999
ISIN
AU000000BIT4
FIGI
BBG000BBLHC8
Biotron Ltd. engages in the funding and management of research, development, and commercialization of drugs targeting significant viral diseases. It is developing the compound BIT225 for the treatment of HIV-1. The company was founded in February 1999 and is headquartered in North Ryde, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BIT is 0.018 AUD — it hasn't changed in the past 24 hours. Watch BIOTRON LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BIOTRON LIMITED stocks are traded under the ticker BIT.
BIT stock has risen by 5.88% compared to the previous week, the month change is a −10.00% fall, over the last year BIOTRON LIMITED has showed a −81.82% decrease.
BIT stock is 0.00% volatile and has beta coefficient of 0.94. Track BIOTRON LIMITED stock price on the chart and check out the list of the most volatile stocks — is BIOTRON LIMITED there?
Yes, you can track BIOTRON LIMITED financials in yearly and quarterly reports right on TradingView.
BIT net income for the last half-year is −2.11 M AUD, while the previous report showed −1.32 M AUD of net income which accounts for −59.59% change. Track more BIOTRON LIMITED financial stats to get the full picture.
No, BIT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOTRON LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOTRON LIMITED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOTRON LIMITED stock shows the sell signal. See more of BIOTRON LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.